IBEX Limited (NASDAQ:IBEX – Get Free Report) insider Christina O’Connor sold 2,376 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The stock was sold at an average price of $39.34, for a total value of $93,471.84. Following the transaction, the insider owned 26,855 shares in the company, valued at $1,056,475.70. The trade was a 8.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Christina Al Trofimuk-O’connor also recently made the following trade(s):
- On Tuesday, September 15th, Christina O’Connor sold 7,500 shares of IBEX stock. The shares were sold at an average price of $40.30, for a total value of $302,250.00.
IBEX Stock Down 1.3%
Shares of IBEX stock traded down $0.52 during trading on Wednesday, reaching $40.28. The company’s stock had a trading volume of 291,941 shares, compared to its average volume of 125,513. IBEX Limited has a 12-month low of $25.94 and a 12-month high of $42.40. The company has a market capitalization of $534.92 million, a P/E ratio of 12.87 and a beta of 0.72. The business has a 50 day moving average price of $36.26 and a 200-day moving average price of $31.97.
Trending Headlines about IBEX
Here are the key news stories impacting IBEX this week:
- Positive Sentiment: IBEX announced that it won a 2026 Globee Award for excellence in an AI-powered customer-experience solution. The recognition supports the company’s positioning in the growing AI-enabled business-process-outsourcing market. ibex Wins 2026 Globee Award for AI-Powered Customer Experience Solution Excellence
- Positive Sentiment: Recent reports highlight IBEX’s efforts to use AI solutions to gain market share and adjust its delivery mix between nearshore and offshore operations. These initiatives could improve scalability, service capabilities and margins if executed successfully. IBEX touts AI solutions to grow market share IBEX shifts from nearshore to offshore
- Positive Sentiment: IBEX’s latest quarterly results modestly exceeded expectations, with earnings per share of $0.85 versus an $0.84 consensus and revenue of $164.27 million versus estimates of $160.02 million. The company reported a 7.19% net margin and 28.96% return on equity.
- Neutral Sentiment: Analyst sentiment remains cautious: Robert W. Baird raised its price target to $40 but kept a neutral rating, while the consensus rating is “Hold” with an average target of $40. The stock’s recent advance has placed it close to that consensus valuation.
- Negative Sentiment: Multiple insiders sold shares around $39.34–$40.41, including CEO Robert Dechant, COO David Afdahl, directors Mingzhe Zhuang and Daniella Ballou-Aares, and other insiders. The sales totaled more than 56,000 shares across the disclosed transactions and reduced several holdings substantially, creating a negative insider-ownership signal. Some transactions, including sales by Dechant, Afdahl and Paul Inson, were made under pre-arranged Rule 10b5-1 plans. SEC insider transaction filing
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Lazard Asset Management LLC lifted its stake in IBEX by 55.2% in the 1st quarter. Lazard Asset Management LLC now owns 89,150 shares of the company’s stock valued at $2,391,000 after buying an additional 31,697 shares in the last quarter. Globeflex Capital L P purchased a new position in IBEX during the second quarter worth $3,112,000. Tieton Capital Management LLC purchased a new position in IBEX during the second quarter worth $8,353,000. Sierra Summit Advisors LLC acquired a new position in shares of IBEX in the fourth quarter worth $879,000. Finally, Y Intercept Hong Kong Ltd raised its holdings in shares of IBEX by 121.8% in the first quarter. Y Intercept Hong Kong Ltd now owns 95,665 shares of the company’s stock worth $2,566,000 after acquiring an additional 52,526 shares during the last quarter. 81.24% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research analysts have weighed in on IBEX shares. Wall Street Zen lowered shares of IBEX from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Robert W. Baird lifted their price target on shares of IBEX from $35.00 to $40.00 and gave the company a “neutral” rating in a research report on Friday, September 11th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of IBEX in a research note on Friday, July 31st. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $40.00.
Get Our Latest Stock Analysis on IBEX
About IBEX
IBEX Limited (NASDAQ: IBEX) is a global business process outsourcing and customer experience company. It provides digitally enabled customer support and operational services for brands across industries including e-commerce, health and fitness, fintech, logistics, retail, travel and utilities.
The company’s services include customer care, technical support, sales and customer acquisition, back-office processing, trust and safety, and other specialized business support functions. IBEX combines contact center personnel, analytics, automation and artificial intelligence-enabled tools to help clients manage customer interactions across voice, digital and other communication channels.
IBEX serves clients primarily in North America and other international markets through delivery operations in locations including the United States, the Philippines, Jamaica, Nicaragua and Pakistan.
See Also
- Five stocks we like better than IBEX
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.
